A Candidate Therapeutic Monoclonal Antibody Inhibits Both HRSV and HMPV Replication in Mice

A Candidate Therapeutic Monoclonal Antibody Inhibits Both HRSV and HMPV Replication in Mice

Human metapneumovirus (HMPV) and human respiratory virus (HRSV) are two leading causes of acute respiratory tract infection in young children. While there is no licensed drug against HMPV, the monoclonal antibody (mAb) Palivizumab is approved against HRSV for prophylaxis use only. Novel therapeutics...

Full description

Bibliographic Details
Main Authors:	Hugues Fausther-Bovendo, Marie-Eve Hamelin, Julie Carbonneau, Marie-Christine Venable, Liva Checkmahomed, Pierre-Olivier Lavoie, Marie-Ève Ouellet, Guy Boivin, Marc-André D’Aoust, Gary P. Kobinger
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	Biomedicines
Subjects:	HMPV HRSV therapeutic antibodies
Online Access:	https://www.mdpi.com/2227-9059/10/10/2516

Similar Items

Innate Immune Components That Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections
by: Catalina A. Andrade, et al.
Published: (2020-06-01)

Changes in the Etiology of Acute Respiratory Infections among Children in Novosibirsk, Russia, between 2019 and 2022: The Impact of the SARS-CoV-2 Virus
by: Olga G. Kurskaya, et al.
Published: (2023-04-01)

Strain-Dependent Impact of G and SH Deletions Provide New Insights for Live-Attenuated HMPV Vaccine Development
by: Julia Dubois, et al.
Published: (2019-10-01)

Bacterial and Viral Coinfections with the Human Respiratory Syncytial Virus
by: Gaspar A. Pacheco, et al.
Published: (2021-06-01)

Non-Coding RNAs and Their Role in Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV) Infections
by: Wenzhe Wu, et al.
Published: (2020-03-01)

In Vitro Anti-HMPV Activity of Meroditerpenoids from Marine Alga Stypopodium zonale (Dictyotales)
by: Maria Teresa Villela Romanos, et al.
Published: (2011-10-01)

Metapneumovirus humano (hMPV) asociado con exacerbación de asma aguda bronquial severa Human Metapneumovirus (hMPV) associated to severe bronchial asthmatic crisis
by: M. A. López, et al.
Published: (2006-09-01)

Recent Molecular Evolution of Human Metapneumovirus (HMPV): Subdivision of HMPV A2b Strains
by: Naganori Nao, et al.
Published: (2020-08-01)

Recombinant BCG Vaccines Reduce Pneumovirus-Caused Airway Pathology by Inducing Protective Humoral Immunity
by: Jorge A. Soto, et al.
Published: (2018-12-01)

Impact of SARS-CoV-2 Pandemic and Lockdown on the HRSV Circulation: Experience of Three Spoke Hospitals in Northern Italy
by: Francesca Parola, et al.
Published: (2024-02-01)

New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV
by: Nicolás M. S. Gálvez, et al.
Published: (2017-08-01)

HMPV in Immunocompromised Patients: Frequency and Severity in Pediatric Oncology Patients
by: Cesar Martinez-Rodriguez, et al.
Published: (2020-01-01)

Clinical comparison of HMPV and RSV infections in hospitalised Malaysian children: A propensity score matched study
by: David Chun‐Ern Ng, et al.
Published: (2024-03-01)

Human Metapneumovirus (hMPV) Infection and MPV467 Treatment in Immunocompromised Cotton Rats <i>Sigmodon hispidus</i>
by: Kevin C. Yim, et al.
Published: (2023-02-01)

RSV and HMPV Infections in 3D Tissue Cultures: Mechanisms Involved in Virus-Host and Virus-Virus Interactions
by: Johan Geiser, et al.
Published: (2021-01-01)

Identification of γ-Fagarine as a novel antiviral agent against respiratory virus (hMPV) infection
by: Jinhua Li, et al.
Published: (2023-10-01)

A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus
by: Emma Rey-Jurado, et al.
Published: (2017-09-01)

Diversity in Glycosaminoglycan Binding Amongst hMPV G Protein Lineages
by: Penelope Adamson, et al.
Published: (2012-12-01)

Use of an Innovative Web-Based Laboratory Surveillance Platform to Analyze Mixed Infections Between Human Metapneumovirus (hMPV) and Other Respiratory Viruses Circulating in Alberta (AB), Canada (2009–2012)
by: Shamir Mukhi, et al.
Published: (2012-11-01)

M2-2 gene as a new alternative molecular marker for phylogenetic, phylodynamic, and evolutionary studies of hRSV
by: Denis Bruno S.M. Nunes, et al.
Published: (2022-09-01)

Development of a novel multi-epitope mRNA vaccine candidate to combat HMPV virus
by: Shiyang Ma, et al.
Published: (2024-12-01)

Human Respiratory Syncytial Virus Infection in a Human T Cell Line Is Hampered at Multiple Steps
by: Ricardo de Souza Cardoso, et al.
Published: (2021-02-01)

Human Respiratory Syncytial Virus Epidemiological Burden in Pediatric Outpatients in Italy: A Systematic Review
by: Sara Boccalini, et al.
Published: (2023-09-01)

Effects of Different Drug Combinations in Immunodeficient Mice Infected with an Influenza A/H3N2 Virus
by: Zeineb Mhamdi, et al.
Published: (2020-12-01)

A chimeric influenza virus vaccine expressing fusion protein epitopes induces protection from human metapneumovirus challenge in mice
by: Tian Chongyu, et al.
Published: (2023-12-01)

Current developments and prospects on human metapneumovirus vaccines
by: Verónica Araceli Márquez-Escobar
Published: (2017-05-01)

Female offspring gestated in hypothyroxinemia and infected with human Metapneumovirus (hMPV) suffer a more severe infection and have a higher number of activated CD8+ T lymphocytes
by: Samanta C. Funes, et al.
Published: (2022-09-01)

Mitoxantrone Shows In Vitro, but Not In Vivo Antiviral Activity against Human Respiratory Syncytial Virus
by: Patricia G. de la Sota, et al.
Published: (2021-09-01)

The Structure of the Human Respiratory Syncytial Virus M2-1 Protein Bound to the Interaction Domain of the Phosphoprotein P Defines the Orientation of the Complex
by: Muniyandi Selvaraj, et al.
Published: (2018-12-01)

Persistent Human Metapneumovirus Infection in Immunocompromised Child
by: Yacine Abed, et al.
Published: (2008-05-01)

In Vitro Properties and Virulence of Contemporary Recombinant Influenza B Viruses Harboring Mutations of Cross-Resistance to Neuraminidase Inhibitors
by: Clément Fage, et al.
Published: (2018-12-01)

Performance of indirect immunofluorescence assay, immunochromatography assay and reverse transcription-polymerase chain reaction for detecting human respiratory syncytial virus in nasopharyngeal aspirate samples
by: LRA Vaz-de-Lima, et al.
Published: (2008-08-01)

In silico analysis of amino acid variation in human respiratory syncytial virus: insights into immunodiagnostics
by: Claudemir Souza, et al.

Genetic variability in G2 and F2 region between biological clones of human respiratory syncytial virus with or without host immune selection pressure
by: Claudia Trigo Pedroso Moraes, et al.
Published: (2015-02-01)

Molecular Epidemiology and Genetic Diversity of Human Respiratory Syncytial Virus in Sicily during Pre- and Post-COVID-19 Surveillance Seasons
by: Fabio Tramuto, et al.
Published: (2023-08-01)

Interactions between the Nucleoprotein and the Phosphoprotein of Pneumoviruses: Structural Insight for Rational Design of Antivirals
by: Hortense Decool, et al.
Published: (2021-12-01)

Human respiratory syncytial virus subgroups A and B outbreak in a kindergarten in Zhejiang Province, China, 2023
by: Shelan Liu, et al.
Published: (2024-02-01)

Imaging analysis reveals budding of filamentous human metapneumovirus virions and direct transfer of inclusion bodies through intercellular extensions
by: Farah El Najjar, et al.
Published: (2023-10-01)

Human Metapneumovirus Phosphoprotein Independently Drives Phase Separation and Recruits Nucleoprotein to Liquid-Like Bodies
by: Kerri Beth Boggs, et al.
Published: (2022-06-01)

Prospects of and Barriers to the Development of Epitope-Based Vaccines against Human Metapneumovirus
by: Ekaterina Stepanova, et al.
Published: (2020-06-01)